Meda focuses on five key therapy areas: respiratory, cardiology, dermatology, pain and inflammation, and CNS. In 2010, products in these therapy areas generated about 80% of total sales.

The gastroenterology area has now become significant following the acquisition of Alaven in 2010, and OTC products have been gradually growing in importance.